Effects of diltiazem and long-term beta1-adrenergic blockade on hemodynamics and blood flow during excersise in ptients with stable angina pectoris  by Ogasawara, Sadamasa et al.
184 JACC Vol. 15, No. 6 
January 1 :1&Q-8 
SADAMASA OGASAWARA, MD, S. BEN FREEDMAN, , 
DAVID T. KELLY, MB, FACC 
Sydney, New South Wales, Australia 
The short-term effec 
and distribution f
semiupright bicycle xercise were evaluated in eight 
tients with stable effort angina on long-term 
adrenergic blockade. Cardiac 
flow were measured using t 
were xercised to the same work load on a bicycle before 
and 2 h after oral diltiazem (60 mg in two patients and 120 
mg in six). 
At ma&nal exercise, diltiazem reduced heart rate from 
94 f 5 to 8% * 6 beats/n& (p < 0.00, mean arterial 
pressure from 139 * 
output during exercise but 1 
Exercise not only increases the total cardiac output but 
alters its distribution so that blood flow to exercising muscle 
is increased in normal subjects (l-4). Antianginal gents 
with strong vasodilator effects have been shown to alter 
adversely this regional distribution to exercising muscle 
(S-7) and may limit exercise capacity (5,6). Diltiazem, a 
benzothiazepine calcium antagonist drug with mild periph- 
eral vasodilation, is an effective antianginal agent alone (8,9) 
and in combination with beta-adrenergic blocking agents 
(10,ll). The purpose of this study was to determine whether 
diltiazem alters the physiologic distribution ofblood flow to 
the legs during bicycle xercise in patients with stable ffort 
angina on long-term beta,-blockade. 
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Study patients. Eight men with a mean age of 59 years 
(range 45 to 66) were studied within 3 weeks of core nary 
arteriography. All patients had stable ffort angina ~~ct~ris 
and a positive xercise lectrocardiogram (ECG) for ische- 
mia. Five patients had a history of prior myocardial infarc- 
tion. Coronary angiography revealed one vessel disease 
(>70% luminal diameter reduction) in five patients, two 
vessel disease in two patients and three vessel disease in 
one. The mean left ventricular ejection fraction was 60% 
(range 44% to 79%). Patients with unstable angina, recent 
acute myocardial infarction (within 8 weeks), clinical con- 
gestive heart failure, significant valvular heart disease or 
peripheral vascular disease v.ere excluded. 
All patients were studied on long-term beta,-selective 
blockade with either metoprolol (100 to 200 mg/day) or 
atenolol(50 to 100 mg/day) for angina pectoris. No patients 
had taken a calcium channel antagonist for at least 48 b 
before the study or a nitrate other than sublingual nitroglyc- 
erin for 24 h. The protocol was approved by the Ethics 
Review Committee at this institution and all patients gave 
written informed consent to the study. 
Study protocol. This study was an open within-patient 
evaluation ofthe hemodynamic eifects da single oral dose 
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Control 
Rest 56 _t 3 138 +4 4.1 c 0.3 86 c 4 18.7 ir 8.2 0.27 k 0.08 32 I 2 
Sub (30 WI 49 c 4 128 t 5 7.8 + 0.5 99 c 6 12.7 t 1.0 0.71. k 0.05 5.5 1 r 
Max (63 W) 94k5 140 c 5 I I.0 + 0.6 119 + II 9.7 c 0.7 1.42 r 0.14 61 3 2 
Diltiazem 
Rest 55 2 4 102 5 4 4.7 2 0.3 87 r’ 6 17.4 + 1.3 0.25 ? 0.02 30t I 
Sub (30 WI 74 + 6” 116 + 65 1.6 2 0.5 106 c 9 81.7 of: 0.8 0.78 k 0.09 55 2 I 
Max (63 W) 88 2 4* 127 ?I 4* 11.2 f 0.3 131 2 KP 8.4 + 0.4* 8.36 + (1.57 64k3 
.01 diltiazem versus comsponding level during control exercise. Data are mean values + SEM. CQ = cardiac, output; HR = heart rate; 
MAP = mean arterial pressure: Max = maximal exercise: 0, Ext = svstemis oxygen extraction; Sub = submaximal exercise; SV = stroke volume; SVR = 
systemic vascular resistance; *02 = syste ic oxygen consu&tion. 
e first exercise test, six patients were given 
orally alnd two were given 60 
he patient was repositioned on t 
were repeated and the exercise protocol 
easuremlents and samples were taken at 
ose of the control study. The 
exercised to the same work load achieved in the control 
study. 
asured va~~a~~es and ca~c~~~~~~~s. Phasic and mean 
al, pulmonary artery, pulmonary artery 
atrial pressures were recorded at rest and in 
of each exercise 
Bow were measu 
iced 5% dextrose in water as 
measurement s;ng this technique c 
with directly *.v in vitro (r = 0.99; 
literslmin) as we have shown previously (6). Total eg blood 
flow was calculated as twice the flow measured inone leg. A 
mean of five cardiac output and six fetr,eral vein flow 
ere were no 
given diltiazem (820 mg) considered separately from 
the two patients given 6 therefore, the results have 
been combined in the statistical nalysis. 
namic and metabolic variables were consistent with normal 
function and zeta-blockade. Patients exercis 
e of 9.5 min at a mean maxims work lo 
ed with either angina pectoris (six patients) 
wo patients). At maxima! exerci 
n (mean I.6 + 0.4 mm) was ob 
eart rate, cardiac output, st 
oxygen consumptios and systemic 
creased as did mean 
vascular resistance decreased. 
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Figure P. Effect of diltiazem on hemo- 
dynamics at rest and during exercise. 
Diltiazem values are indicated by the 
closed circles and joined by 
trol values by closed I 
lines. *p < 0.05, **p < 0.01 
versus corresponding level 
during control exercise test. Error bars 
represent s andard error of the mean. 
rial pressure; MAX = maximal work 
load of 63 W; RPP = rate-pressure 
product; SUB = submaximal work 
load of 30 W; SVR = systemic vascular 
resistance. 
Effects of diltiazem. There were no significant changes in 
rest hemodynanic variables before and after administration 
of diltiazem. At maximal exercise during diltiazem therapy, 
four of six patients who developed angina during the control 
period had no angina nd the remaining two had less angina. 
The two patients who stopped with ieg fatigue iq the control 
i4 
i 2 -L---d CONTRDL 
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Figure 2. Effect of diltiazem on cardiac 
output and leg blood flow at rest and 
during exercise. Dihiazem vahres are 
indicated by the closed circles and 
joined by broken lines, ccrttrol values 
by closed triangles and solid lines. *p < 
0.05 diltiazem versus corresponding 
level during control exercise test. Er- 
ror bars represent s andard error of the 
mean. LEG FLOWIC.0. = proportion 
of cardiac output distributed to legs; 
other abbreviations as in Figure 1. 
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. Effects of dil~iazem onST ression at maximal exercise 
patients. Control values ar 
after diltiazem on the right. Each patient is represented bya line 
joining control and di~ti~em values and group means are plotted to 
the left and right of the individual patient data. 
astolic and mean 
mic vascular resis 
cardiac output was 
ased, stroke volume 
versus 25 2 2 mm 
I versus 10 -C 2 
cmm5. At maxima! exercise, the leg bloo 
4.6 -I- 0.3 litersimin, and the femoral vascular esistance 
decreased to 46 -t 4 x IO* dynes-s-cm-‘. Leg oxygen 
exercise, so there was no s 
cardiac output distributed to the exercising legs is signifi- 
cantly reduced, presumably by the vasodilator effect on 
scular beds. This effect may cause fatigue 
ltiazem is not as powerful avasodilator and 
in this study did not alter either cardiac output or the 
Table 2. Effect of Diiltiazem on Leg Flow and Metabolism in Eight Patients 
V-A 
Total Leg lliofemorai Iliofemoral Iliofemoral 
Blood Leg Venous Lactate Lactate 
Flow Flow/CO Leg O2 Leg QOo, Lactate Difference Production 
(liters/min) (%I Ext i%“o) imYn& (mmoYliter) (mmol/liter) (mmoVmin) 
Contro! 
Rest 0.48 f 0.05 11 2 2 41 ” 2 33 t 4 0.3 c 0.1 0.04 t 0.03 0.02 + 0.02 
Sub (30 W) 3.2 r 0.2 41 2 3 6622 315 rt 36 1.7 k 0.7 0.2 2 0.2 0.5 f 0.4 
Max (63 W) 4.6 r 0.3 43 +I 2 72 + 3 606+44 3.9 -c 0.9 0.5 2 0.3 1.3 + 0.6 
Diltiazem 
West 0.43 ? 0.03 921 45 r 4 35 k 5 0.2 i e.04 0.04 ‘- 0.02 0.01 + 0.01 
Sub (30 W) 3.4 f 0.2 45 _+ 3 64-+6 386 2 51 1.3 + 0.5 0.2 k 0.1 0.1 t 0.3 
Max (63 W) 4.5 2 0.3 4ti f 2 72 2 3 590 + 43 3.3 f 0.8 0.5 ” 0.2 1.3 1 0.5 
Data are mean values k SEM. Leg Flow/CO = proportion of cardiac output distributed lo the leg blood flow: Leg D2 Ext = ilbfemoral oxygen extrac~ioa; 
Leg Q02 = iliofemoral oxygen consumption; V-A = venous-arterial. Other abbreviations as in Table I. 
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proportion ofthe cardiac output distributed tothe exercising 
legs, although the vasodilating action was apparent as mean 
arterial blood pressure and systemic vascular resistance at
maximal exercise were lower than during the control period. 
Rfle& on exercise heart rate. Nifedipine and nisoldipine, 
even in the presence of beta-blockade, produced reflex 
increases in heart rate at rest and during exercise in our 
previous tudies (6,7), resulting in a higher ate-pressure 
product. This effect may be detrimental for patients with 
exercise-induced ischemia. In contrast, diltiazem decreased 
heart rate during exercise, resulting in a decrease in rate- 
pressure product and increase in stroke volume. 
Effects on ischemia and ventricular fun&m. The combi- 
nation of diltiazem with beta-blockade has been shown to 
decrease ischemic symptoms and to prolong exercise time 
(lo,1 I). In this study diltiazem produced additional ntiangi- 
nal effects, reducing angina and ischemic ST depression 
during exercise. The reduction of ischemia t maximal 
exercise with diltiazem is probably due to a lower myocar- 
dial oxygen demand as heart rate, systemic loading and 
rate-pressure product decreased. The combined use of beta- 
blockade and diltiazem could paentially cause left ventric- 
ular dysfunction, although this combination is usually well 
tolerated (10,ll). In this study stroke volume was signifi- 
cantly increased and pulmonary wedge pressure decreased 
slightly though not significantly at maximal exercise after 
diltiazem, suggesting that Beft ventricular function was im- 
proved, probably as a consequence of less ischemia. 
Limitations ofthe study. Thermodilution was used in this 
study to measure l g blood flow and has been used by other 
investigators (12,13). Measurements are not specific for 
muscle because total leg flow is measured and includes a 
component of flow to nonmuscular tissue. This factor as- 
sumes less importance during exercise as nonmuscular flow 
becomes relatively small and leg flow approximates exercis- 
ing muscle flow more closely. 
This was a single dose study of diltiazem in patients on 
long-term beta,-blockade. We were aware of the possible 
order effect of this study deign, but it was not possible to 
reverse the order of exercise tests, as this would have 
influenced the results of the second exercise test. The first 
two patients were given 60 mg diltiazem and the remainder 
received 120 mg diltiazem. Apart from the PR interval, there 
were no differences in the results when the six patients given 
120 mg were analyzed separately, sothe statistical nalysis 
has been reported for all eight patients. 
cih&al ilBp~icatio~s. During exercise in patients With 
angina, the addition of diltiazem to a beta-blocking a ent 
imprOVes angina threshold and reduces i chemia but does 
got alter the distribution ofblood flow to exercising muscle. 
This contrasts with the dihydropyridine calcium an?agonist 
drugs, which are more powerful systemic vasodiiators an 
reduce the proportion of cardiac output distributed toexer- 
cising muscle. Because fatigue may limit exercise before the 
onset of angina in patients on dihydropyridine calcium 
antagonists, he combination f diltiazem and beta-blockade 
may offer some therapeutic advantage in patients with 
chronic stabk sr@;aa who are physically active. 
We acknowledge the expert technical assistance of Leena Mitra-Duncan, BSc 
and th;: cooperation of cardiologists and research personnel at the Hallstrom 
Institute, Camperdown. Sydney, New South Wales, Australia. 
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